Phase I study of humanized monoclonal antibody AVE1642 directed against the type 1 insulin-like growth factor receptor (IGF-1R), administered in combination with anticancer therapi... by Macaulay, V, Middleton, M, Protheroe, A, Tolcher, A, Dieras, V, Sessa, C, Bahleda, R, Blay, J, LoRusso, P, Mery-Mignard, D, Soria, J